Artia Global Partners LP
CIK 1937964 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $541.9M
- Posisi
- 48
- Per tanggal
- 30 Juni 2026
#3.587 dari 9.443 berdasarkan nilai 13F · top 38.0%
Nilai portofolio QoQ: +8.5% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 64,55%
- Bobot 25 kepemilikan teratas
- 88,35%
- Posisi di atas 1%
- 23
- Jumlah posisi efektif
- 17,5
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 15,28% Perkiraan pembelian $140.996.646 · penjualan $79.556.713
Kepemilikan median: 2,0 kuartal Dilacak Q4 2024–Q2 2026 · 41,4% masih dipegang
- Posisi baru
- 8
- Meningkat
- 11
- Menurun
- 3
- Tertutup
- 9
Eksposur put-notional: 2,9% put 13F melaporkan posisi opsi pada nilai notional yang mendasarinya — dapat mencakup lindung nilai, tidak selalu taruhan bearish
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +26.3% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 93,3% · Opsi dikecualikan: 10,1%
Rincian sektor
Healthcare
96,2%
Lainnya/Tidak terpetakan
3,8%
Portofolio lengkap 48 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| ABVX Abivax SA - American Depositary Shares | $68.821.727 | 12,70% | 516.447 | $1.928.549 | Turun ×1 | ||
| INSM Insmed Incorporated - Common Stock | $62.804.724 | 11,59% | 589.052 | $-40.002.262 | Turun ×4 | ||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $41.232.390 | 7,61% | 2.210.852 | $17.210.118 | Naik ×1 | ||
| BTSG BrightSpring Health Services, Inc. - Common Stock | $36.077.548 | 6,66% | 517.315 | $33.785.130 | Naik ×2 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $34.719.839 | 6,41% | 185.390 | $22.564.561 | Naik ×2 | ||
| ARGX argenx SE - American Depositary Shares | $27.590.952 | 5,09% | 29.739 | $5.874.047 | |||
| ALKS Alkermes plc - Ordinary Shares | $23.523.469 | 4,34% | 448.964 | Naik ×1 | |||
| TVTX Travere Therapeutics, Inc. - Common Stock | $19.260.465 | 3,55% | 339.033 | $17.159.968 | Naik ×1 | ||
| AZN AstraZeneca PLC - American Depositary Shares | $18.654.057 | 3,44% | 98.376 | $-155.998 | Naik ×1 | ||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $17.078.391 | 3,15% | 503.936 | $947.400 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $15.888.265 | 2,93% | 162.990 | $2.210.144 | |||
| XBI XBI | $15.825.000 | 2,92% | 100.000 | Opsi jual | |||
| DGX Quest Diagnostics Incorporated Common Stock | $13.802.608 | 2,55% | 65.122 | $5.803.292 | Naik ×1 | ||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $11.447.573 | 2,11% | 144.376 | $606.379 | |||
| EYPT EyePoint, Inc. - Common Stock | $10.969.501 | 2,02% | 767.098 | $1.081.608 | |||
| ALMS Alumis Inc. - Common Stock | $7.838.284 | 1,45% | 278.546 | $677.521 | Turun ×1 | ||
| VKTX Viking Therapeutics, Inc. - Common Stock | $7.050.316 | 1,30% | 180.731 | $1.169.329 | |||
| CELC Celcuity Inc. - Common Stock | $6.205.640 | 1,15% | 59.316 | $4.427.795 | Naik ×2 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $6.022.933 | 1,11% | 70.700 | $4.948.600 | Naik ×1 | ||
| MRK Merck & Company, Inc. Common Stock (new) | $6.000.950 | 1,11% | 46.700 | $383.407 | |||
| RAPP Rapport Therapeutics, Inc. - Common Stock | $5.771.628 | 1,07% | 138.508 | $1.437.713 | |||
| JNJ Johnson & Johnson Common Stock | $5.739.722 | 1,06% | 22.600 | $215.378 | |||
| GH Guardant Health, Inc. - Common Stock | $5.716.143 | 1,05% | 38.100 | Naik ×1 | |||
| ABSI Absci Corporation - Common Stock | $5.382.906 | 0,99% | 464.444 | Naik ×1 | |||
| SRRK Scholar Rock Holding Corporation - Common Stock | $5.295.675 | 0,98% | 96.285 | $562.304 | |||
| SION Sionna Therapeutics, Inc. - Common Stock | $5.267.407 | 0,97% | 119.741 | $466.990 | |||
| Penerbit tidak dikenal (CUSIP: K08588103) | $4.731.613 | 0,87% | 17.740 | Naik ×1 | |||
| ROIV Roivant Sciences Ltd. - Common Shares | $4.593.622 | 0,85% | 129.800 | $998.162 | |||
| PALI Palisade Bio, Inc. - Common Stock | $4.164.047 | 0,77% | 1.992.367 | $677.405 | |||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $4.014.244 | 0,74% | 98.800 | $1.950.994 | Naik ×1 | ||
| BIIB Biogen Inc. - Common Stock | $3.983.498 | 0,74% | 18.437 | $603.443 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $3.923.400 | 0,72% | 65.000 | $143.650 | |||
| BLTE Belite Bio, Inc - American Depositary Shares | $3.847.931 | 0,71% | 24.989 | $-136.315 | |||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $3.717.844 | 0,69% | 137.800 | $-15.158 | |||
| PROK ProKidney Corp. - Class A Ordinary Shares | $3.686.156 | 0,68% | 1.806.939 | $451.735 | |||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $3.659.075 | 0,68% | 72.100 | $2.839.795 | Naik ×1 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $3.178.678 | 0,59% | 33.400 | ||||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $2.813.334 | 0,52% | 22.951 | $396.407 | Naik ×1 | ||
| UTHR United Therapeutics Corporation - Common Stock | $2.709.150 | 0,50% | 5.000 | $-255.750 | |||
| DRUG Bright Minds Biosciences Inc. - common stock | $2.696.171 | 0,50% | 38.407 | $-106.388 | |||
| KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | $1.867.340 | 0,34% | 29.200 | $461.360 | |||
| CMPX Compass Therapeutics, Inc. - Common Stock | $839.208 | 0,15% | 383.200 | Naik ×1 | |||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $836.975 | 0,15% | 2.500 | $31.500 | |||
| KOD Kodiak Sciences Inc - Common Stock | $663.060 | 0,12% | 17.019 | $14.296 | |||
| TENX Tenax Therapeutics, Inc. - Common Stock | $612.264 | 0,11% | 42.080 | $-60.595 | |||
| NUVL Nuvalent, Inc. - Class A Common Stock | $605.150 | 0,11% | 4.900 | $103.145 | |||
| PEPG PepGen Inc. - Common Stock | $369.583 | 0,07% | 205.324 | $6.160 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $355.120 | 0,07% | 4.000 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| ALKS | $23.523.469 | 448.964 | 4,34% |
| XBI | $15.825.000 | 100.000 | 2,92% |
| GH | $5.716.143 | 38.100 | 1,05% |
| ABSI | $5.382.906 | 464.444 | 0,99% |
| Penerbit tidak dikenal (CUSIP: K08588103) | $4.731.613 | 17.740 | 0,87% |
| ORKA | $3.178.678 | 33.400 | 0,59% |
| CMPX | $839.208 | 383.200 | 0,15% |
| SYRE | $355.120 | 4.000 | 0,07% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| INSM | Dipangkas | -40K | -$40.0M |
| RVMD | Beli lebih banyak | +60K | +$22.6M |
| TRVI | Beli lebih banyak | +197K | +$17.2M |
| ARGX | Hanya pergerakan harga | +0 | +$5.9M |
| DGX | Beli lebih banyak | +24K | +$5.8M |
| CELC | Beli lebih banyak | +44K | +$4.4M |
| ELVN | Beli lebih banyak | +51K | +$2.8M |
| DNTH | Hanya pergerakan harga | +0 | +$2.2M |
| EWTX | Beli lebih banyak | +33K | +$2.0M |
| ABVX | Dipangkas | -84K | +$1.9M |
3 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| VRNA | 31 Des. 2025 | 379.004 | $40.443.517 | Tidak lagi dilacak |
| NVO | 31 Maret 2025 | 450.000 | $38.709.000 | -33,0% |
| LLY | 30 Juni 2026 | 38.220 | $35.153.609 | 5,7% |
| UGL | 31 Maret 2026 | 542.119 | $30.098.447 | Tidak lagi dilacak |
| ITCI | 30 Juni 2025 | 219.719 | $28.985.330 | Tidak lagi dilacak |
| MRUS | 31 Des. 2025 | 296.750 | $27.939.013 | Tidak lagi dilacak |
| QURE | 31 Maret 2026 | 1.023.539 | $24.493.288 | 193,0% |
| VRTX | 31 Des. 2025 | 55.100 | $21.579.364 | 20,0% |
| BSX | 31 Des. 2025 | 183.200 | $17.885.816 | -46,0% |
| CDTX | 31 Maret 2026 | 70.824 | $15.644.313 | Tidak lagi dilacak |
| ACLX | 30 Juni 2025 | 229.085 | $15.027.976 | Tidak lagi dilacak |
| PCVX | 31 Maret 2025 | 162.255 | $13.282.194 | 63,1% |
| MRNA | 30 Juni 2026 | 200.000 | $10.160.000 | 104,5% |
| XBI | 31 Maret 2025 | 100.000 | $9.006.000 | Tidak lagi dilacak |
| XBI | 30 Sep. 2025 | 100.000 | $8.293.000 | Tidak lagi dilacak |
| ALNY | 31 Maret 2026 | 17.400 | $6.919.110 | -27,8% |
| RARE | 31 Des. 2025 | 214.502 | $6.452.220 | 15,5% |
| NUVL | 30 Juni 2025 | 90.745 | $6.435.635 | Tidak lagi dilacak |
| VTYX | 31 Maret 2026 | 695.982 | $6.284.717 | Tidak lagi dilacak |
| PVLA | 31 Maret 2026 | 59.200 | $6.196.464 | 15,7% |
| REGN | 31 Des. 2025 | 10.671 | $5.999.983 | 8,2% |
| TERN | 30 Juni 2026 | 104.800 | $5.525.056 | Tidak lagi dilacak |
| RNA | 31 Maret 2026 | 60.100 | $4.335.013 | 1,9% |
| ASND | 30 Juni 2026 | 17.740 | $4.057.670 | -2,8% |
| NKTR | 31 Des. 2025 | 57.999 | $3.300.143 | 76,9% |
| CNTA | 31 Des. 2025 | 133.291 | $3.232.307 | Tidak lagi dilacak |
| ABBV | 30 Juni 2026 | 14.500 | $3.153.605 | 5,4% |
| SWTX | 30 Sep. 2025 | 63.930 | $3.004.071 | Tidak lagi dilacak |
| OCUL | 31 Maret 2026 | 226.261 | $2.746.809 | 35,2% |
| RYTM | 30 Juni 2025 | 50.000 | $2.648.500 | 78,8% |
| CRNX | 31 Maret 2025 | 45.765 | $2.339.964 | 152,5% |
| ELVN | 31 Maret 2025 | 102.900 | $2.315.250 | 194,4% |
| SLNO | 30 Juni 2026 | 68.490 | $2.293.045 | Tidak lagi dilacak |
| VRDN | 30 Juni 2025 | 160.000 | $2.156.800 | 72,7% |
| TGTX | 31 Des. 2025 | 54.515 | $1.969.354 | 75,8% |
| UPB | 31 Maret 2026 | 68.653 | $1.863.929 | -19,0% |
| ISRG | 30 Juni 2025 | 3.500 | $1.733.445 | -27,3% |
| NBIX | 30 Juni 2025 | 14.700 | $1.625.820 | 23,2% |
| IREN | 31 Des. 2025 | 33.200 | $1.558.076 | 12,0% |
| BBIO | 30 Juni 2026 | 20.400 | $1.514.904 | 11,8% |
| NAMS | 31 Maret 2025 | 54.285 | $1.395.124 | 36,6% |
| EWTX | 31 Maret 2025 | 50.000 | $1.335.000 | 103,9% |
| BHVN | 31 Des. 2025 | 80.000 | $1.200.800 | 23,2% |
| CRL | 31 Maret 2025 | 6.305 | $1.163.903 | 93,3% |
| TARS | 31 Maret 2025 | 20.811 | $1.152.305 | 40,9% |
| MREO | 31 Des. 2025 | 475.361 | $979.244 | -26,3% |
| ANNX | 31 Maret 2025 | 172.226 | $883.519 | 175,9% |
| SRPT | 31 Des. 2025 | 44.900 | $865.223 | -11,0% |
| TECX | 31 Maret 2025 | 16.650 | $768.731 | 104,2% |
| ATYR | 31 Des. 2025 | 972.276 | $701.400 | -33,8% |
| MRNA | 31 Des. 2025 | 23.800 | $614.754 | 385,7% |
| ANRO | 31 Maret 2026 | 29.192 | $519.618 | 52,2% |
| CNTA | 30 Juni 2025 | 35.226 | $506.550 | Tidak lagi dilacak |
| KALV | 31 Des. 2025 | 41.555 | $506.140 | Tidak lagi dilacak |
| APGE | 30 Juni 2026 | 5.886 | $495.425 | 1,5% |
| JANX | 30 Sep. 2025 | 20.000 | $462.000 | -28,8% |
| AVTX | 30 Juni 2026 | 28.970 | $432.522 | 9,7% |
| ALEC | 31 Des. 2025 | 71.029 | $210.246 | 55,8% |
| ORKA | 30 Juni 2025 | 7.380 | $75.719 | 854,5% |
| LYRA | 31 Maret 2026 | 8.756 | $26.968 | Tidak lagi dilacak |